Skip to main content

Life Sciences

By Anthony Vecchione | 01:47 pm | June 27, 2025
Cirrus uses fMRI imaging to acquire and generate maps of critical brain networks to assist with brain surgery planning.  
By Jessica Hagen | 12:24 pm | June 27, 2025
The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.
By Jessica Hagen | 05:09 pm | June 26, 2025
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 
By Jessica Hagen and Anthony Vecchione | 02:36 pm | June 24, 2025
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.   
By HIMSS TV | 12:00 pm | June 24, 2025
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.
By Anthony Vecchione | 03:56 pm | June 23, 2025
Amazon Diagnostics provides home sample collection in under 60 minutes and lab results in less than six hours.  
By Anthony Vecchione | 03:15 pm | June 20, 2025
The company's virtual reality and augmented reality apps pair with external neurofeedback or biofeedback wearable devices.  
By Anthony Vecchione | 01:56 pm | June 20, 2025
Employees will have access to medications through Cost Plus Drugs and 9amHealth's care team of obesity medical specialists.  
By Anthony Vecchione | 04:05 pm | June 19, 2025
The funds will be used to increase the company's research and development initiatives and expand its workforce.